ACT EU: MSP AG – Call for Expressions of Interest
📢 🔔Take a look at the below ‘Call for Expressions of Interest’ from the Multi-stakeholder Platform Advisory Group (MSP AG) under ACT EU: ▶️ Message from ACT EU: MSP AG “Call for Expression of Interest – Focus Group on the review of the Guideline for...![[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]](https://cddf.org/wp-content/uploads/2026/02/202602_INNOVATIVE-ONCOLOGY-TRIAL-DESIGNS_TIME-TO-ACT-1080x675.jpg)
[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]
While the CDDF Annual Conference 2026 is in full swing, we are thrilled to announce the publication of our latest white paper: “Innovative oncology trial designs: Time to act – A review with recommendations of the Cancer Drug Development Forum.” This paper was largely...
Key Takeaways of the CDDF ACT-EU Webinar Series
The Cancer Drug Development Forum (CDDF) is pleased to share the key takeaways from our recent ACT-EU webinar series, “Collaborating with stakeholders to define priorities for clinical trials and working collectively to address them.” The first session was held on 15...